1. Nagant de Deuxchaisnes C: Calcitonin in the treatment of Paget’s disease. Triangle 1983; 22: 103–128.
2. Nagant de Deuxchaisnes C: Use of calcitonin in the treatment of postmenopausal osteoporosis, In DeLuca HF, Mazess R (eds.): Osteoporosis. Physiological Basis, Assessment, and Treatment. New York, Elsevier, 1990, pp 247–258.
3. Nagant de Deuxchaisnes C: Medical management of Paget’s disease, In DeGroot LJ (ed.): Endocrinology, 2nd ed. Vol 2. Philadelphia, WB Saunders, 1989, pp 1211–1244.
4. Nagant de Deuxchaisnes C, Devogelaer JP: Surveillance et suivi à long terme de la maladie osseuse de Paget (except English summary), In Simon L, Sebert JL, Hérisson C (eds.): La Maladie Osseuse de Paget. Actualités. Paris, Masson, 1989, pp 257–273.
5. Nagant de Deuxchaisnes C, Devogelaer JP, Huaux JP, et al: Effect of a nasal spray of salmon calcitonin in normal subjects and in patients with Paget’s disease of bone, In Pecile A (ed.): Calcitonin 1984. Amsterdam, Elsevier Science Publishers BV, 1985, pp 329–343.